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AbsTrACT
Objective To determine the prevalence of, associations 
with and diagnoses leading to mild visual impairment or 
worse (logMAR >0.3) in middle-aged adults in the UK 
Biobank study.
Methods and analysis Prevalence estimates for 
monocular and binocular visual impairment were 
determined for the UK Biobank participants with fundus 
photographs and spectral domain optical coherence 
tomography images. Associations with socioeconomic, 
biometric, lifestyle and medical variables were investigated 
for cases with visual impairment and matched controls, 
using multinomial logistic regression models. Self-reported 
eye history and image grading results were used to identify 
the primary diagnoses leading to visual impairment for a 
sample of 25% of cases.
results For the 65 033 UK Biobank participants, aged 
40–69 years and with fundus images, 6682 (10.3%) and 
1677 (2.6%) had mild visual impairment or worse in one 
or both eyes, respectively. Increasing deprivation, age 
and ethnicity were independently associated with both 
monocular and binocular visual impairment. No primary 
diagnosis for the recorded level of visual impairment 
could be identified for 49.8% of eyes. The most common 
identifiable diagnoses leading to visual impairment were 
cataract, amblyopia, uncorrected refractive error and 
vitreoretinal interface abnormalities.
Conclusions The prevalence of visual impairment 
in the UK Biobank study cohort is lower than for 
population-based studies from other industrialised 
countries. Monocular and binocular visual impairment 
are associated with increasing deprivation, age 
and ethnicity. The UK Biobank dataset does not 
allow confident identification of the causes of visual 
impairment, and the results may not be applicable to the 
wider UK population.
InTrOduCTIOn
At present, data on the prevalence, associ-
ations with and diagnoses leading to visual 
impairment among middle-aged adults in 
the UK, especially those of working age, are 
lacking. Reliable prevalence data do exist 
but mainly for children and the elderly or 
for those with certifiable visual impairment. 
For middle-aged adults, the most widely 
used data come from a number of interna-
tional, population-based studies, many of 
which concluded almost 20 years ago.1 Given 
the recent increases in obesity and diabetes 
mellitus and national differences in ethnicity, 
smoking history and socioeconomic status, 
the findings of these studies may not be rele-
vant to the current UK population.
UK Biobank is a voluntary, cross-sec-
tional study of UK residents that aims to 
investigate how lifestyle, environment and 
genes influence the health of adults, aged 
40–69 years, in the UK.2 The size and breadth 
of the UK Biobank dataset provides a unique 
Key messages
What is already known about this subject?
Current and reliable data on the prevalence of, 
associations with and diagnoses leading to monocular 
and binocular impairment is lacking, particularly for 
middle-aged adults.
What are the new findings?
In this study with UK Biobank participants, the 
prevalence of monocular and binocular visual 
impairments was 10.3% and 2.6%, respectively. 
Increasing Townsend deprivation score, age and 
ethnicity were independently associated with 
both monocular and binocular visual impairments. 
Uncorrected refractive error, cataract, amblyopia and 
vitreoretinal interface abnormalities were the common 
identifiable causes of visual impairment. Despite the 
use of self-reported eye history, fundus photographs 
and spectral domain optical coherence tomography 
images, no identifiable cause for the recorded level of 
visual impairment was found in almost half the eyes.
How might these results change the focus of 
research or clinical practice? 
The UK Biobank dataset does not allow confident 
identification of the primary causes of visual 
impairment. However, most of the visual impairment 
in middle-age with an identifiable cause would be 
amenable to treatment. Despite the large number of 
participants, results from the dataset may still not be 
applicable to the wider UK population. Future research 
should explore the reasons behind the association of 
visual impairment with deprivation and ethnicity.  on
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opportunity to collect accurate data on the prevalence 
and causes of visual impairment among participants. The 
aims of this project were to determine the prevalence 
of monocular and binocular visual impairment among 
UK Biobank participants, to investigate associations with 
known and potential socioeconomic, biometric, lifestyle 
and medical variables and to determine the causes of 
visual impairment among UK Biobank participants using 
self-reported eye history and image grading.
MATerIAls And MeTHOds
study population
Over the course of 2006–2010, UK Biobank recruited 
503 325 participants at 22 centres by postal invitation 
(5.47% response rate).2 Data collection during the 
baseline and enhanced assessments has been reported 
elsewhere.3–5 Deprivation was assessed using the 
Townsend score: a measure of deprivation for each post-
code area, derived from census data on employment, 
household overcrowding, car and home ownership.
Additional enhancements to the baseline assessment 
visit were included for the collection of eye data from 
2009. This included visual acuity with habitual correc-
tion, using a semiautomated system using logMAR 
optotypes, autorefraction and self-reported eye history 
for 133 668 participants, of whom 65 033 also underwent 
colour fundus photography and spectral domain optical 
coherence tomography (OCT) imaging. From these 
65 033 UK Biobank participants with imaging, 8359 cases 
had mild visual impairment or worse (logMAR >0.3 or 
Snellen >6/12) in at least one eye and were matched 
with controls, without visual impairment, by age (5 year 
bands), sex and ethnic group at a ratio of 1:4.
In a nested pilot study, the ability to identify both the 
primary cause of and associations with visual impair-
ment, using self-reported eye history and image grading, 
was investigated in a subset of 25% of those with visual 
impairment and fundus imaging. Cases for the nested 
pilot study were selected in order to be representative of 
all participants with visual impairment in terms of visual 
acuity, age, sex and ethnicity.
The UK Biobank project received approval from the 
North-West Multicentre Research Ethics Committee. 
Approval was also obtained for access to anonymised UK 
Biobank data by researchers, without the need for addi-
tional approvals.
baseline and enhanced assessments
Data collection during the baseline and enhanced assess-
ments has been reported elsewhere.3–5 In brief and of 
relevance to the eye, this comprised a history of spectacle 
or contact lens wear, eye surgery and disease, logMAR 
acuity, refractive error and fundus imaging. Using the 
Topcon 3D-OCT 1000 Mark 2 (Topcon Corporation, 
Tokyo, Japan), a single non-mydriatic, 45° digital, colour 
image, centred on the fovea, and a spectral domain OCT 
cube scan of the macula, covering a 6 mm*6 mm retinal 
area (128 horizontal line scans comprised of 512 A-scans) 
were captured for both eyes.
Analysis of fundus photographs and OCT images
Images were analysed using the Topcon OCT viewer 
software (V.4.21, Topcon Corporation) by experienced 
clinicians or by non-medical graders, certified for the 
detection and classification of diabetic retinopathy by the 
National Health Service (NHS) Diabetes Eye Screening 
Programme. Fundus photographs were assessed for 
image quality, media opacity, optic disc or retinal vascular 
or other abnormalities and the presence of signs of age-re-
lated maculopathy. OCT images were assessed for image 
quality, vitreoretinal interface abnormalities (VRIA) and 
intraretinal abnormalities. The presence or absence of 
ocular abnormalities and disease was confirmed using 
standard definitions.6–10 Image quality grades are defined 
in online supplementary table 1. The main reason for 
adequate or inadequate images was assessed as being 
either technical or the result of media opacity.
Assigning the primary diagnosis leading to visual impairment
Using the results of image grading and the level of visual 
impairment, together with self-reported eye history, 
graders assigned the primary diagnosis leading to visual 
impairment for each eye in a sample of 25% of the cases. 
(These cases were selected in order to be representative 
of the larger group of all participants with visual impair-
ment in terms of the degree of visual impairment, age, 
sex and ethnicity.) For eyes in which no cause was identi-
fied, the presence or absence of habitual correction at the 
time visual acuity was recorded, and the refractive errors 
were noted. For the eyes with unaided visual impairment, 
uncorrected refractive error was considered to be the 
cause of visual impairment when no other pathology was 
identified and there was a spherical equivalent of ≥−1DS 
or ≥+2 DS for mild visual impairment (logMAR >0.3 to 
<0.45), ≥−1.5 DS or ≥+3 DS for moderate visual impair-
ment (logMAR 0.45 to <1.0), ≥−3DS or ≥+6 DS for severe 
visual impairment (logMAR 1.0 to <1.3) and ≥−4DS 
or ≥+8 DS for blindness (logMAR ≥1.3). As the best-cor-
rected visual acuity was not recorded for participants, 
it was not possible to identify if participants with visual 
impairment despite habitual correction were also under-
corrected. Visual acuity data was incomplete for one eye 
of 36 cases, and only the visual acuity data for the fellow 
eye was included.
statistical analysis
Descriptive statistics were used to report the prevalence 
and primary diagnoses leading to visual impairment 
in the UK Biobank participants. The characteristics 
of the cases were initially compared with the controls 
using descriptive statistics, both for all cases and then 
according to monocular or binocular visual impairment 
status. Univariate multinomial logistic regression models 
were used to investigate the association between known 
risk factors and other predetermined socioeconomic, 
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biometric, lifestyle and medical variables and both binoc-
ular and monocular visual impairment compared with 
the matched controls. Those factors found to be associ-
ated with visual impairment at a 10% level (to account 
for potential correlation between factors) were then 
included in a multivariable multinomial logistic regres-
sion model. Only those that were significantly associated 
(P<0.05) with visual impairment remained in the final 
multivariable model. Although the cases and controls 
were matched by age, sex and ethnic group, it is recom-
mended also to adjust for these variables to account for 
any remaining differences; therefore, the final multivari-
able models included these variables irrespective of their 
association with visual impairment.11 The final multi-
variable model was checked for colinearity (r>0.7 and 
P<0.05) between variables included in the model, and no 
evidence was found.
resulTs
From the 65 033 UK Biobank participants with imaging 
and self-reported eye history, 8359 had mild visual impair-
ment or worse in at least one eye. The majority (6682: 
80%) had monocular visual impairment, and the degree 
of visual impairment was typically mild or moderate 
(online supplementary table 2). As a proportion of all 
the eligible UK Biobank participants with baseline and 
extended eye assessments (65 033), the prevalence of 
monocular and binocular visual impairment was 10.3% 
(95% CI 10.0% to 10.5%) and 2.6% (95% CI 2.5% to 
2.7%), respectively. The prevalence of mild, moderate, 
severe visual impairment and blindness in the better-
seeing eye of those with binocular visual impairment was 
1.63% (95% CI 1.53% to 1.73%), 0.92% (95% CI 0.85% 
to 0.99%), 0.03% (95% CI 0.02% to 0.04%) and 0%, 
respectively. The estimated prevalence of the same cate-
gories in the worse-seeing eye of those with monocular 
visual impairment was 5.7% (95% CI 5.5% to 5.9%), 4.0% 
(95% CI 3.8% to 4.2%), 0.57% (95% CI 0.51% to 0.63%) 
and 0.06% (95% CI 0.04% to 0.08%), respectively.
There were differences in the baseline descriptive 
statistics in relation to ethnicity, deprivation, employment 
status, smoking status, medications and self-reported 
health conditions between the 8359 cases and the 24 438 
matched controls (online supplementary table 3). For 
example, 25.5% of cases lived in the most deprived quin-
tile compared with 21.4% of the controls. There would 
also appear to be proportionally more cases with binoc-
ular visual impairment living in deprived areas, compared 
with those with monocular visual impairment. Of those 
with binocular visual impairment (1677), 30.9% lived in 
the most deprived quintile compared with only 24.1% of 
those with monocular visual impairment (6682).
The following factors were found to be significantly (at 
5% level) associated with monocular or binocular visual 
impairment, compared with controls: age, ethnicity, 
deprivation, employment, systolic blood pressure, waist 
hip ratio, current smoking status, the presence of a 
smoker in household, medication for hypertension or 
hypercholesterolaemia and a history of diabetes mellitus, 
cardiovascular or cerebrovascular disease (online supple-
mentary table 4). These factors were included in a 
multivariable model to identify independent factors 
associated with visual impairment. Sex (as a matching 
variable) and estimated total retinol daily intake (as 
associated with the outcome at the 10% level) were also 
included in the multivariable model. Only age, ethnicity 
and deprivation remained significantly (at 5% level) asso-
ciated with monocular and binocular visual impairments 
(online supplementary table 4). Those living in the most 
deprived quintile were 25% more likely than those in the 
least deprived quintile to have monocular visual impair-
ment rather than no impairment, and 84% more likely 
to have binocular visual impairment, on adjustment 
for differences in age, sex and ethnic group. With each 
increasing decade of age, the risk of monocular visual 
impairment increases by 13%, and the risk of binocular 
visual impairment increases by 24%, adjusting for ethnic 
group, sex and deprivation differences. Black and other 
ethnic participants were 29% and 53%, respectively, 
more likely to have binocular visual impairment rather 
than none, compared with white participants, accounting 
for age, sex and deprivation differences. However, no 
significant association was found between ethnicity and 
monocular visual impairment compared with none, with 
or without adjustment for age, sex and deprivation differ-
ences, indicating that the association between ethnicity 
and visual impairment may only apply to binocular visual 
impairment.
For the sample of 25% of the cases with visual impair-
ment, the primary diagnoses leading to monocular and 
binocular visual impairments are shown in online supple-
mentary table 5. In both the better-seeing and worse-seeing 
eyes of those with binocular visual impairment, the most 
common identifiable causes were uncorrected refractive 
error, cataract and vitreoretinal interface disease. For 
the cases with monocular visual impairment, the most 
common identifiable causes were cataract, self-reported 
amblyopia and uncorrected refractive error. No primary 
cause for the level of visual impairment could be identi-
fied for up to 49.8% of eyes with visual impairment.
The majority of OCT images were of high quality, with 
the quality of 1836 (73.5%) images rated as good and 
550 (22.0%) rated as adequate. The quality of the colour 
fundus photographs was lower with 1157 (46.3%) images 
rated as good, 811 (32.5%) rated as adequate, due to 
either technical issues (649) or media opacity (162), and 
528 (21.2%) images were felt to be of inadequate quality, 
due to either technical issues (429) or media opacity 
(99).
dIsCussIOn
For the UK Biobank population with baseline and 
extended eye data, the prevalence of monocular and 
binocular visual impairment was 10.3% and 2.6%, respec-
tively. Visual impairment was associated with increasing 
age and deprivation and ethnic minority status. Cataract, 
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amblyopia and uncorrected refractive error were the 
most common identifiable causes of visual impairment. 
However, despite access to self-reported eye history, 
autorefraction, colour fundus photography and spectral 
domain OCT imaging, it was not possible to identify the 
primary cause of visual impairment for almost 50% of 
participants.
The prevalence of both binocular and monocular 
visual impairment in the UK Biobank cohort is lower than 
for many studies from other industrialised countries.5 
For an urban Canadian population aged 40 years and 
over, Robinson et al reported a binocular visual impair-
ment prevalence of 2.7%.12 Among residents of Victoria, 
Australia, VanNewkirk et al13 recorded that the preva-
lence of any visual impairment was 4.2%, although both 
visual acuity and visual field were included in the defini-
tion of visual impairment. Similarly, Rahi et al14 identified 
binocular visual impairment with habitual correction 
in 4.5% of British adults aged 44 or 45 years. However, 
for the NHANES study population, Vitale et al reported 
visual impairment prevalence figures of 4.3% and 8.8% 
among adults aged 40–59 years and aged 60 years and 
over, respectively, and in a systematic review, Bourne et al 
estimated the prevalence of moderate visual impairment 
of worse to be 3.9% for Western European adults aged 
over 50 years.1 15 For monocular visual impairment, the 
British Birth Cohort reported a prevalence of 11.9% with 
habitual correction among a comparable group of adults 
aged 44 or 45 years.14 Much higher figures were reported 
for other studies. The Blue Mountains Eye Study reported 
prevalence figures of 3.6% and 8.2% among adults aged 
49–59 years and 60–69 years, respectively.16 Nowak et al 
reported a prevalence of monocular visual impairment of 
27.5% among adults aged 35–97 in Poland.17 Much of the 
difference in the reported prevalence may be explained 
by differences in the age and sex of the participants in 
each study, the definitions of visual impairment and by 
the nature of the studies themselves.18
The UK Biobank study used the Townsend score 
to record deprivation. This index is determined by 
combining four census variables and can be calculated 
for any geographical area including postcodes. Increasing 
deprivation was associated with both monocular and 
binocular visual impairment among UK Biobank partic-
ipants. This association has been reported before, both 
for UK Biobank and other populations.4 5 19 However, 
it is unclear whether increasing deprivation adds to the 
risk of visual impairment by, for example, delaying access 
to eye care services, even though such services are often 
free within the UK NHS or is a consequence of visual 
impairment and downward social drift. In this study, 
employment status was associated with both monocular 
and binocular visual impairments on univariate analysis 
only. However, Cumberland et al identified an associa-
tion between visual impairment and a range of economic 
variables, including employment, income and household 
structure, in a larger study involving UK Biobank partici-
pants.5 Given the association between visual impairment 
and socioeconomic status, initiatives to tackle preventable 
visual impairment may help to address health inequality.
Black or black British and other (non-white, or Asian 
or black) ethnicity were also positively associated with 
binocular visual impairment. Although the number 
of cases with these ethnicities was small, associations 
between visual impairment and ethnicity have been 
described before for both UK and US populations.20 21 
While glaucoma and diabetic retinopathy are common 
diagnoses leading to severe visual impairment and blind-
ness in people of black ethnicity, cataract is the more 
common diagnoses of milder visual impairment in the 
same population.22 Increasing age was also associated 
with categories of visual impairment, even those cases 
and controls were matched in 5-year age bands. No signif-
icant, independent association was found with the other, 
predetermined biometric, lifestyle and medical variables. 
This may reflect the low prevalence of visual impair-
ment due to retinal vascular diseases, such as age-related 
macular degeneration, diabetic retinopathy and retinal 
vascular occlusion, in the study population.
For the UK Biobank participants with binocular visual 
impairment, uncorrected refractive error and cata-
ract were the two most common identifiable diagnoses 
leading to visual impairment in the better-seeing eye. 
These two conditions were the largest causes of both 
mild and moderate visual impairment, but inherited 
retinal disease and myopic degeneration were the largest 
causes of severe visual impairment. In contrast to the 
sight impairment certification data, age-related macular 
degeneration, glaucoma and diabetic retinopathy were 
uncommon diagnoses leading to visual impairment.23 
Shweikh et al reported a 1.7% prevalence of self-re-
ported glaucoma among UK Biobank participants, but 
mean visual acuity was good at better than logMAR 0.1 in 
each eye, so that the contribution of glaucoma to visual 
impairment based on an acuity definition alone may be 
smaller than expected.4 In a systematic review, Bourne et 
al estimated that uncorrected refractive error and cata-
ract were the most common causes of moderate and 
severe visual impairment in adults in Western Europe, 
with refractive error accounting for almost 50% of the 
visual impairment burden.1 Many other studies have also 
reported that uncorrected refractive error accounts for 
the majority of visual impairment in adults from devel-
oped nations.12–15
For monocular visual impairment, cataract, amblyopia 
and uncorrected refractive error were the most common 
identifiable diagnoses leading to visual impairment. 
For moderate or worse visual impairment, self-reported 
amblyopia was the single most common diagnosis. In 
the Blue Mountains Eye Study, amblyopia was the most 
frequent diagnosis leading to mild or worse unilateral 
visual impairment in persons aged 49–59 years, but 
cataract was the most common cause of mild unilateral 
visual impairment in older people.9 16 Similarly, Nowak 
et al reported that uncorrected refractive error, ambly-
opia, cataract and ARMD were the most common causes 
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of monocular visual impairment among adults, aged 
35–97 years, and data from the British Birth Cohort 
suggest that refractive error accounted for 43% of monoc-
ular visual impairment.14 17 By contrast, in the Salisbury 
Eye Evaluation Study, involving American adults aged 
65–84 years, ARMD, other retinal diseases, trauma and 
amblyopia were the most common causes of monocular 
blindness.24
No primary cause for the recorded level of visual 
impairment could be identified in almost half of the eyes 
in the nested study. Visual acuity in the UK Biobank study 
was recorded using a semiautomated computerised test, 
based on the EDTRS logMAR chart. Although this test 
system has not yet been validated within a similar study 
population, it seems unlikely that there are significant 
errors in the recording of visual acuity as LogMAR vision 
charts are considered to be the reference standard for 
assessing visual function. Self-reported use of either 
spectacles or contact lenses was over 80%, both for partic-
ipants with and without visual impairment.18 Habitual 
correction worn at the time of the visual acuity test was 
assumed to be correct, and uncorrected refractive error 
was only considered to be a potential cause of visual 
impairment when either there was no habitual correction 
or the correction was reported as forgotten. The absence 
of a best-corrected or pin-hole acuity measure makes it 
likely that the contribution of uncorrected refractive 
error may have been underestimated.25 26 The absence 
of lens or anterior segment images and slit-lamp exam-
ination also means that underdiagnosis may also apply to 
cataract, especially as a cause of mild and moderate visual 
impairment. The inclusion of spectral domain OCT 
images may have contributed to a higher prevalence of 
visual impairment due to vitreoretinal interface disease 
was then expected.
Image quality was generally good, particularly for the 
OCT images. The inclusion of the OCT images is likely 
to have aided in the diagnosis of macular oedema and 
VRIA.27 Even when the quality of either image was graded 
as inadequate, it was often possible to derive some infor-
mation that could be used for grading, either from the 
inadequate image itself or the other image. This was most 
often the case when the fundus photograph was graded 
as inadequate, but the OCT image was graded as good 
or adequate. MacGillivray et al also identified problems 
with the quality of the colour fundus images among UK 
Biobank participants.28
This study has a number of strengths and potential 
weaknesses. The UK Biobank project was large and had 
good geographical coverage. It was one of the first to 
collect spectral domain OCT images and over 65 000 
participants had baseline and extended eye data, meeting 
the criteria for inclusion in this study. Many of the key 
findings in relation to the causes of and associations 
with visual impairment are consistent with other studies. 
However, the UK Biobank study is not a population-based 
study, and the response rate to the invitation to participate 
was very low. Participants were generally healthier, older, 
more affluent and more likely to be urban than the full 
UK population and so may not be representative.3 5 18 26 
This study also involved only those participants with base-
line and enhanced eye assessments. As a result, the visual 
impairment prevalence figures reported here may not be 
applicable to the wider UK population and are likely to 
be minimum prevalence estimates. Furthermore, for the 
cases with both monocular and binocular visual impair-
ments, no cause was identified in almost 50% of cases. 
Habitual correction was assumed to be correct, and this 
may have underestimated the contribution of refrac-
tive error. Similarly, many eyes may have more than one 
diagnosis leading to visual impairment. Without a single 
pathology to explain all of the impairment, no diagnosis 
would be recorded for these eyes, potentially reducing 
the overall contribution of both refractive error and 
ocular pathology. Finally, the diagnosis of monocular and 
binocular amblyopia was also based on the self-reported 
eye history and normal imaging but did not take account 
of refractive error.29 Limiting the analysis to UK Biobank 
participants with both baseline and extended eye data 
may also have caused the study to be underpowered.5
The prevalence of visual impairment of any level in the 
UK Biobank cohort is lower than for population-based 
studies from other industrialised countries. Although 
visual impairment was typically mild or moderate, monoc-
ular and binocular visual impairment were associated 
with increasing age and deprivation and ethnic minority 
status. Cataract and uncorrected refractive error were the 
most common identifiable causes of both monocular and 
binocular visual impairments. Despite access to self-re-
ported eye history and both fundus photographs and 
spectral domain OCT images, no cause was identified 
for the level of visual impairment recorded in almost half 
the cases. Therefore, the methodology used in the UK 
Biobank study may be inadequate to identify the primary 
causes of visual impairment with confidence. Results 
from analysis of the UK Biobank dataset may also not be 
applicable to the wider UK population.
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